Hereditary Neuropathy - complex
Gene: PLP1
Not an established gene-disease association - emerging evidence present suggesting that neuropathy is a feature of PMD.
PMID: 20301361
Referred to as PLP1 null syndrome - Characterised as peripheral neuropathy along with ataxia and spastic quadriparesis but in the absence of nystagmus present within the first decade of life.
Individuals diagnosed with PLP1 null syndrome generally ambulate better than those with classic PMD but may progress more rapidly because of degeneration of axons.Created: 7 Aug 2023, 11:53 p.m. | Last Modified: 7 Aug 2023, 11:53 p.m.
Panel Version: 0.215
Mode of inheritance
X-LINKED: hemizygous mutation in males, biallelic mutations in females
Phenotypes
Pelizaeus-Merzbacher disease (MIM#312080)
Publications
Gene: plp1 has been classified as Amber List (Moderate Evidence).
Phenotypes for gene: PLP1 were changed from Pelizaeus-Merzbacher disease; Infantile-onset, nystagmus, cognitive impairment, spasticity and ataxia, leukodystrophy on MRI, mild multifocal SNCV neuropathy seen with null mutations and more mild phenotype of mild spasticity and ataxia; HMSN to Pelizaeus-Merzbacher disease (MIM#312080)
Publications for gene: PLP1 were set to
Gene: plp1 has been classified as Amber List (Moderate Evidence).
gene: PLP1 was added gene: PLP1 was added to Hereditary Neuropathy - complex_RMH. Sources: Royal Melbourne Hospital,Expert Review Green Mode of inheritance for gene: PLP1 was set to X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males) Phenotypes for gene: PLP1 were set to Pelizaeus-Merzbacher disease; Infantile-onset, nystagmus, cognitive impairment, spasticity and ataxia, leukodystrophy on MRI, mild multifocal SNCV neuropathy seen with null mutations and more mild phenotype of mild spasticity and ataxia; HMSN